SCHEMBL2994989

SCHEMBL2994989

Cc1c(CC(=O)O)c2c(Cl)c(O)ccc2n1C(=O)c1ccc(C(F)(F)F)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.39
PTGS2 P35354 3/20 0.39
AKR1C3 P42330 8/20 0.39
AKR1C2 P52895 8/20 0.39
DAO P14920 1/20 0.38
ABCB1 P08183 3/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
PTGES O14684 1/20 0.36
ABCC3 O15438 1/20 0.36
ABCC4 O15439 1/20 0.36
ABCB11 O95342 1/20 0.36
MT-CO2 P00403 1/20 0.36
LMNA P02545 1/20 0.36
ALB P02768 1/20 0.36
CYP1A2 P05177 1/20 0.36
ALOX5 P09917 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CXCL8 P10145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004782 0.89 AKR1C3 (0.41) PTGS1PTGS2AKR1C3AKR1C2DAO
SCHEMBL2007386 0.87 AKR1C3 (0.42) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2005742 0.87 AKR1C3 (0.43) PTGS1PTGS2AKR1C3AKR1C2DAO
SCHEMBL2006596 0.86 PTGS1 (0.45) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2002163 0.86 PTGS1 (0.43) PTGS1PTGS2AKR1C3AKR1C2DAO
SCHEMBL2004705 0.86 PTGS1 (0.43) PTGS1PTGS2AKR1C3AKR1C2DAO
SCHEMBL2007169 0.85 PTGS2 (0.40) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2003568 0.85 PTGS2 (0.38) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2005252 0.85 PTGS1 (0.41) PTGS1PTGS2AKR1C3AKR1C2DAO
SCHEMBL2008757 0.84 PTGS1 (0.39) PTGS1PTGS2AKR1C3AKR1C2DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20070203209-A1 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PTGS1 34/4885PTGS2 45/4885AKR1C3 1274/4885
US-20070203209-A1 Useful indole compounds TPH2, HRH2, HRH1 PTGS1 159/4885PTGS2 67/4885AKR1C3 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.